Reduction in the Healthcare Business segment's loss
First written in FY2021. 6 of 15 entries say "Advanced", first in FY2022-Q2. Latest entry: FY2026-H1.
0 other companies' latest entry also says "Other".
- FY2026-H1Interim Consolidated Segment Results DisclosedAnnual report
「As a result, revenue was ¥105.667 million and the segment loss was ¥8.059 million.」
Interim consolidated revenue of ¥105.667 million and a segment loss of ¥8.059 million were disclosed for the healthcare business. - FY2025AdvancedAnnual report
「Revenue from the healthcare business was ¥164.150 million, up 5.1% from the previous fiscal year, and the segment loss was ¥8.231 million, compared with a segment loss of ¥18.075 million in the previous fiscal year.」
Revenue from the healthcare business increased, while the segment loss narrowed from ¥18.075 million in the previous fiscal year to ¥8.231 million. - FY2025-H1AdvancedAnnual report
「As a result, revenue was ¥85.631 million, down 5.4% from the previous interim accounting period, and segment profit was ¥1.036 million, compared with a segment loss of ¥10.707 million in the previous interim accounting period.」
Although revenue from the healthcare business declined, results shifted from a segment loss in the previous period to segment profit of ¥1.036 million. - FY2024WorsenedAnnual report
「Revenue from the healthcare business was ¥156.117 million, up 0.4% from the previous fiscal year, and the segment loss was ¥18.075 million, compared with segment profit of ¥457,000 in the previous fiscal year.」
Revenue from the healthcare business increased only marginally, while results shifted from profit of ¥457,000 in the previous fiscal year to a loss of ¥18.075 million. - FY2024-Q2WorsenedAnnual report
「As a result, revenue was ¥90.528 million, up 15.0% from the same quarter of the previous year, and the segment loss was ¥10.707 million, compared with segment profit of ¥1.203 million in the same quarter of the previous year.」
Although revenue from the healthcare business increased, segment results shifted from profit in the previous period to a loss of ¥10.707 million. - FY2024-Q1WorsenedAnnual report
「As a result, revenue was ¥41.047 million, up 16.4% year on year, and the segment loss was ¥565,000, compared with a segment loss of ¥362,000 in the cumulative first quarter of the previous year.」
Although revenue from the healthcare business increased, the segment loss widened from ¥362,000 in the same period of the previous year to ¥565,000. - FY2023AdvancedAnnual report
「Revenue from the healthcare business was ¥155.570 million, down 4.8% from the previous fiscal year, and segment profit was ¥457,000, compared with a segment loss of ¥3.192 million in the previous fiscal year.」
Although revenue from the healthcare business declined, it reported segment profit of ¥457,000 for the full year, turning profitable from a loss of ¥3.192 million in the previous fiscal year. - FY2023-Q3Cumulative Third-Quarter Segment Results UpdatedAnnual report
「As a result, revenue was ¥122.011 million, down 2.2% from the same quarter of the previous year, and segment profit was ¥2.887 million, down 0.9%.」
The healthcare business reported segment profit of ¥2.887 million for the nine months ended in the third quarter and remained profitable, although both revenue and profit declined from the same quarter of the previous year. - FY2023-Q2AdvancedAnnual report
「As a result, revenue was ¥80.975 million, down 3.6% from the same quarter of the previous year, and segment profit was ¥316,000, down 72.1%.」
The business reported segment profit of ¥316,000 for the six months ended in the second quarter, turning profitable from the ¥276,000 loss in the cumulative first quarter. However, profit declined 72.1% from the same quarter of the previous year. - FY2023-Q1AdvancedAnnual report
「As a result, revenue was ¥36.457 million, down 7.1% year on year, and the segment loss was ¥276,000, compared with a segment loss of ¥559,000 in the cumulative first quarter of the previous year.」
The healthcare business posted a segment loss of ¥276,000 in the first quarter, but the loss narrowed from ¥559,000 in the same period of the previous year. - FY2022WorsenedAnnual report
「Revenue from the healthcare business was ¥165.085 million and the segment loss was ¥1.542 million, compared with a segment loss of ¥1.467 million in the previous fiscal year.」
Although the business was profitable on a cumulative basis through the second and third quarters, it posted a segment loss of ¥1.542 million for the full year, widening the loss from ¥1.467 million in the previous fiscal year. - FY2022-Q3Profitability maintained through the nine months ended in the third quarterAnnual report
「As a result, revenue was ¥124.716 million and segment profit was ¥2.912 million, down 44.1% from the same quarter of the previous year.」
The healthcare business continued to report segment profit of ¥2.912 million for the nine months ended in the third quarter and remained profitable. However, profit was down 44.1% from the same quarter of the previous year. - FY2022-Q2AdvancedAnnual report
「As a result, revenue was ¥83.971 million and segment profit was ¥1.136 million, up 37.8% from the same quarter of the previous year.」
The healthcare business reported segment profit of ¥1.136 million for the six months ended in the second quarter, an increase of 37.8% from the same quarter of the previous year. - FY2022-Q1First-quarter segment loss disclosedAnnual report
「As a result, revenue was ¥39.259 million and the segment loss was ¥559,000.」
First-quarter revenue of ¥39.259 million and a segment loss of ¥559,000 were disclosed for the healthcare business. Because the period differs from the previous full-year results, no conclusion was drawn that the loss reduction had progressed. - FY2021First statedAnnual report
「Revenue from the healthcare business was ¥145.921 million, down 3.8% year on year, while the operating loss was ¥1.467 million, compared with an operating loss of ¥80.113 million in the previous fiscal year.」
Although revenue from the healthcare business declined, the operating loss narrowed from ¥80.113 million in the previous fiscal year to ¥1.467 million.